keyword
https://read.qxmd.com/read/38312440/serotonin-syndrome-and-neuroleptic-malignant-syndrome-a-case-report-of-intersecting-symptomatology
#21
Loulwa Maktabi, Denver Shipman, Justin P Reinert
INTRODUCTION: Serotonin syndrome and neuroleptic malignant syndrome are caused by 2 distinct pathologies; however, the clinical presentation associated with both syndromes share many features. METHODS: We describe a 56-year-old male patient who presented to our facility with seizures, leukocytosis, fevers, extremity hyperreflexia, and signs of autonomic dysfunction as evidenced by cardiovascular instability. The patient was noted to be taking vortioxetine, trazodone, lamotrigine, lurasidone, and carbidopa-levodopa as outpatient medications for his depression, an unspecified mood disorder, and Parkinson disease...
February 2024: Mental Health Clinician
https://read.qxmd.com/read/38311073/the-effectiveness-of-vortioxetine-on-neurobiochemical-metabolites-and-cognitive-of-major-depressive-disorders-patients-a-8-week-follow-up-study
#22
JOURNAL ARTICLE
Yiliang Zhang, Shunkai Lai, Jianzhao Zhang, Ying Wang, Hui Zhao, Jiali He, Dong Huang, Guanmao Chen, Zhangzhang Qi, Pan Chen, Shuya Yan, Xiaosi Huang, Xiaodan Lu, Shuming Zhong, Yanbin Jia
OBJECTIVE: Vortioxetine has been shown to improve cognitive performance in people with depression. This study will look at the changes in neurobiochemical metabolites that occur when vortioxetine improves cognitive performance in MDD patients, with the goal of determining the neuroimaging mechanism through which vortioxetine improves cognitive function. METHODS: 30 depressed patients and 30 demographically matched healthy controls (HC) underwent MCCB cognitive assessment and 1H-MRS...
April 15, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38294154/goal-setting-and-goal-attainment-in-patients-with-major-depressive-disorder-a-narrative-review-on-shared-decision-making-in-clinical-practice
#23
REVIEW
David S Baldwin, Michael Adair, Arun Micheelsen, Daniel Oudin Åstrøm, Elin H Reines
OBJECTIVE: Narrative review of the processes of goal setting and goal attainment scaling, as practical approaches to operationalizing and implementing the principles of shared decision making (SDM) in the routine care of people living with major depressive disorder (MDD). METHODS: We searched electronic databases for clinical studies published in English using key terms related to MDD and goal setting or goal attainment scaling. Two clinical studies of goal setting in MDD are considered in detail to exemplify the practicalities of the goal setting approach...
January 31, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/38287888/update-lessons-from-pet-imaging-part-ii-a-systematic-critical-review-on-therapeutic-plasma-concentrations-of-antidepressants
#24
JOURNAL ARTICLE
Xenia M Hart, Moritz Spangemacher, Julie Defert, Hiroyuki Uchida, Gerhard Gründer
BACKGROUND: Compared with antipsychotics, the relationship between antidepressant blood (plasma or serum) concentrations and target engagement is less well-established. METHODS: We have discussed the literature on the relationship between plasma concentrations of antidepressant drugs and their target occupancy. Antidepressants reviewed in this work are citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, venlafaxine, duloxetine, milnacipran, tricyclic antidepressants (amitriptyline, nortriptyline, and clomipramine), bupropion, tranylcypromine, moclobemide, and vortioxetine...
April 1, 2024: Therapeutic Drug Monitoring
https://read.qxmd.com/read/38284357/the-effect-of-vortioxetine-on-the-nlrp3-pathway-and-microglial-activity-in-the-prefrontal-cortex-in-an-experimental-model-of-depression
#25
JOURNAL ARTICLE
Gulin Ozdamar Unal, Duygu Kumbul, Kuyas Hekimler Ozturk, Gamze Erkılınc, Feyza Donmez, Eltaf Dogan Kıran, Ramazan Oğuz Yuceer
BACKGROUND: Increasing evidence suggests that early life stress (ELS) and neuroinflammation are associated with the pathophysiology of depression. The purpose of this study was to determine the effects of Vortioxetine (VOR), a novel antidepressant, on ELS-induced behavioral changes and neuroinflammation. METHOD: Wistar Albino 4-week-old male rats were divided into four groups: control; chronic unpredictable stress (CUMS), VOR, CUMS + VOR. Neurobehavioral assessment was performed on the first, 21st, and 42nd days...
January 29, 2024: Immunopharmacology and Immunotoxicology
https://read.qxmd.com/read/38256680/switching-to-vortioxetine-in-patients-with-poorly-tolerated-antidepressant-related-sexual-dysfunction-in-clinical-practice-a-3-month-prospective-real-life-study
#26
JOURNAL ARTICLE
Angel L Montejo, Froilán Sánchez-Sánchez, Rubén De Alarcón, Juan Matías, Benjamin Cortés, Claudia Matos, Tomás Martín-Pinto, Peñitas Ríos, Nerea González-García, José María Acosta
UNLABELLED: Treatment-emergent sexual dysfunction (TESD) is one of the most frequent and persistent adverse effects of antidepressant medication. Sexual dysfunction (SD) secondary to SSRIs occurs in >60% of sexually active patients and >80% of healthy volunteers, with this causing treatment discontinuation in >35% of patients. However, this factor is rarely addressed in routine examinations, and only 15-30% of these events are spontaneously reported. A strategy of switching to a different non-serotonergic antidepressant could involve a risk of relapse or clinical worsening due to a lack of serotonergic activity...
January 18, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38256665/the-role-of-vortioxetine-in-the-treatment-of-depressive-symptoms-in-general-hospital-psychiatry-a-case-series-and-prisma-compliant-systematic-review-of-the-literature
#27
REVIEW
Francesco Weiss, Bruno Pacciardi, Giulia D'Alessandro, Valerio Caruso, Icro Maremmani, Stefano Pini, Giulio Perugi
Depressive symptoms are a customary finding in hospitalized patients, particularly those who are undergoing long hospitalizations, underwent major surgical procedures or suffer from high levels of multimorbidity and frailty. The patients included in this case series shared high degrees of frailty-complexity and were evaluated within the ordinary consultation and liaison psychiatry service of the University Hospital in Pisa, Italy, from September 2021 to June 2023. Patients were administered at least one follow-up evaluation after a week and before discharge...
January 17, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38245346/hemerocallis-citrina-baroni-ameliorates-chronic-sleep-deprivation-induced-cognitive-deficits-and-depressive-like-behaviours-in-mice
#28
JOURNAL ARTICLE
Ning Jiang, Yiwen Zhang, Caihong Yao, Fang Chen, Yupei Liu, Yuzhen Chen, Yan Wang, Muhammad Iqbal Choudhary, Xinmin Liu
Sleep deprivation (SD) is common during spaceflight. SD is known to cause cognitive deficits and depression, requiring treatment and prevention. Hemerocallis citrina Baroni (Liliaceae) is a perennial herb with antidepressant, antioxidant, antitumor, anti-inflammatory, and neuroprotective effects.The aim of our study was to investigate the effects of H. citrina extract (HCE) on SD-induced cognitive decline and depression-like behavior and possible neuroinflammation-related mechanisms. HCE (2 g/kg/day, i...
February 2024: Life Sciences in Space Research
https://read.qxmd.com/read/38239870/goal-attainment-scaling-for-depression-validation-of-the-japanese-gas-d-tool-in-patients-with-major-depressive-disorder
#29
JOURNAL ARTICLE
Masaki Kato, Toshiaki Kikuchi, Koichiro Watanabe, Tomiki Sumiyoshi, Yoshiya Moriguchi, Daniel Oudin Åström, Michael Cronquist Christensen
PURPOSE: Goal attainment scaling (GAS) has been proposed as a person-centric, semi-quantitative measure that assimilates achievement of individually set goals into a single standardized "goal attainment score" that can be compared at the population level. We aimed to examine the reliability and validity of the Japanese version of the GAS for depression (GAS-D) tool in assessing goal attainment in people living with major depressive disorder (MDD). PATIENTS AND METHODS: This was a prespecified analysis of a prospective, 24-week, multicenter, observational cohort study of employed Japanese outpatients with MDD initiating treatment with vortioxetine according to the Japanese label (JRCT1031210200)...
2024: Neuropsychiatric Disease and Treatment
https://read.qxmd.com/read/38239711/vortioxetine-usage-in-an-elderly-patient-with-major-depressive-disorder-and-accompanied-by-multiple-physical-conditions-a-case-report
#30
Xiaoman Wang, Xiaoqian Ma, Yicheng Long, Guowei Wu
Elderly patients with depressive disorder always have complex and diverse symptoms, and are mostly combined with chronic physical conditions. This case report presents a case of vortioxetine usage in a 67-year-old male patient with major depressive disorder and accompanied by multiple physical conditions.
December 2023: Aging medicine
https://read.qxmd.com/read/38239568/treatment-of-depression-with-vortioxetine-and-second-generation-antipsychotics-during-the-period-of-remission-formation-in-schizophrenia-interim-data-analysis
#31
JOURNAL ARTICLE
Aleksandr M Reznik, Timur S Syunyakov, Aleksandr V Mudrak, Nikolay B Zakharov, Zhanna B Popova, Anastasia N Khoroshilova, Ilona G Khurbatova, Alina M Saifulina, Anton M Eliseenko, Tatiana K Matvievskaya, Angelina N Khannanova
BACKGROUND: Depression in patients with schizophrenia worsens the course of the disease by increasing the risk of suicide, by complicating the clinical picture of the disorder, and by reducing the quality of the social functioning; its treatment is difficult, since monotherapy, even when involving modern antipsychotics, does not always prove successful. While the prescription of additional antidepressants (ADs) can improve the likelihood of a better outcome, the effectiveness of such augmentation in many cases is yet to be proven...
March 31, 2023: Consort Psychiatr
https://read.qxmd.com/read/38219239/probiotics-for-adults-with-major-depressive-disorder-compared-with-antidepressants-a-systematic-review-and-network-meta-analysis
#32
JOURNAL ARTICLE
Shilin Zhao, Suisha Liang, Jun Tao, Ye Peng, Siqi Chen, Hogan K F Wai, Feng-Ying Chung, Zhen Y Sin, Matthew K L Wong, Andrea M Haqq, Wing C Chang, Michael Y Ni, Francis K L Chan, Siew C Ng, Hein M Tun
CONTEXT: Despite recent advances in antidepressants in treating major depression (MDD), their usage is marred by adverse effects and social stigmas. Probiotics may be an efficacious adjunct or standalone treatment, potentially circumventing the aforementioned issues with antidepressants. However, there is a lack of head-to-head clinical trials between these 2 interventions. OBJECTIVE: A systematic review and network meta-analysis was conducted to compare the efficacy and acceptability of these 2 interventions in treating MDD...
January 14, 2024: Nutrition Reviews
https://read.qxmd.com/read/38195001/physical-health-consequences-of-psychological-conditions
#33
EDITORIAL
Harold G Koenig
No abstract text is available yet for this article.
January 9, 2024: International Journal of Psychiatry in Medicine
https://read.qxmd.com/read/38179956/preparation-of-aromatic-and-heterocyclic-amines-by-the-electrophilic-amination-of-functionalized-diorganozincs-with-polyfunctional-o-2-6-dichlorobenzoyl-hydroxylamines
#34
JOURNAL ARTICLE
Yifan Li, Zongchao Lv, Yunkun Wang, Zhaohua Wan, Paul Knochel, Yi-Hung Chen
We report a catalyst-free electrophilic amination, which enables the synthesis of aromatic and heterocyclic amines. By subjecting diarylzinc or diheteroarylzinc compounds to readily accessible O -2,6-dichlorobenzoyl hydroxylamines in the presence of MgCl2 in dioxane at a temperature of 60 °C (8-16 h). This new electrophilic amination allowed an expedited synthesis of two pharmaceutically significant compounds: vortioxetine is a key intermediate of delamanid. This approach offers opportunities for the streamlined synthesis of amine-based molecules in the pharmaceutical industry...
January 5, 2024: Organic Letters
https://read.qxmd.com/read/38158448/influence-of-crystal-disorder-on-the-forced-oxidative-degradation-of-vortioxetine-hbr
#35
JOURNAL ARTICLE
Dattatray Modhave, Brenda Barrios, Jayant Iyer, Amrit Paudel
The present study investigates the impact of the solid-state disorder of vortioxetine hydrobromide (HBr) on oxidative degradation under accelerated conditions. A range of solid-state disorders was generated via cryogenic ball milling. The solid-state properties were evaluated by calorimetry, infrared-, and Raman spectroscopies. While salt disproportionation occurred upon milling, no chemical degradation occurred by milling. The amorphous fraction remained physically intact under ambient storage conditions. Subsequently, samples with representative disordered fractions were mixed with a solid oxidative stressor (PVP-H2 O2 complex) and were compressed to compacts...
December 29, 2023: AAPS PharmSciTech
https://read.qxmd.com/read/38149102/us-medicaid-program-an-analysis-of-the-spending-and-utilization-patterns-for-antidepressants-from-2017-to-2021
#36
JOURNAL ARTICLE
Mohamed Elmarasi, Brian Fuehrlein
BACKGROUND: Major depressive disorder (MDD) is a serious mental health condition that contributes to health complications, financial burden and death. In 2020, about one in five US adults had a lifetime diagnosis of MDD . With Major Depressive Disorder (MDD) being a common mental health concern, it is important to understand treatment patterns within public health systems like Medicaid, as they play a crucial role in providing care to diverse populations. OBJECTIVE: The study investigated antidepressant usage and market distribution in the Medicaid Program...
March 2024: Explor Res Clin Soc Pharm
https://read.qxmd.com/read/38133585/drugs-for-depressionr
#37
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 11, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38126222/clinical-benefits-and-bioequivalence-of-vortioxetine-oral-drop-solution-versus-oral-tablets
#38
JOURNAL ARTICLE
Andrea Fagiolini, Michael Adair, Kamilla Buchberg Petersen, Johan Areberg, Michael Cronquist Christensen
BACKGROUND: Vortioxetine is efficacious and well tolerated in patients with major depressive disorder (MDD) and is available as an immediate-release tablet and oral drop solution. The oral drop solution may offer clinical benefits versus a tablet, such as the reduced risk of nausea, personalised dosing and ease of administration. AIMS: To investigate the bioequivalence of vortioxetine 20 mg/mL oral drop solution versus a 20 mg immediate-release tablet...
December 21, 2023: Journal of Psychopharmacology
https://read.qxmd.com/read/38114867/impact-of-elevated-body-mass-index-bmi-on-hedonic-tone-in-persons-with-post-covid-19-condition-a-secondary-analysis
#39
JOURNAL ARTICLE
Gia Han Le, Angela T H Kwan, Sabrina Wong, Ziji Guo, Kayla M Teopiz, Sebastian Badulescu, Shakila Meshkat, Giacomo d'Andrea, Roger Ho, Taeho Greg Rhee, Bing Cao, Lee Phan, Joshua D Rosenblat, Rodrigo B Mansur, Mehala Subramaniapillai, Roger S McIntyre
INTRODUCTION: The post-COVID-19 condition (PCC) is characterized by persistent, distressing symptoms following an acute COVID-19 infection. These symptoms encompass various domains, including hedonic tone, which is critical for overall well-being. Furthermore, obesity is both a risk factor for COVID-19 and PCC and associated with impaired hedonic tone. This study aims to investigate whether elevated body mass index (BMI) is associated with hedonic tone in persons with PCC. METHODS: We perform a post hoc analysis of a randomized, double-blind, placebo-controlled clinical trial investigating the impact of vortioxetine on cognitive impairment in persons with PCC...
December 19, 2023: Advances in Therapy
https://read.qxmd.com/read/38104552/vortioxetine-reverses-impairment-of-visuospatial-memory-and-cognitive-flexibility-induced-by-degarelix-as-a-model-of-androgen-deprivation-therapy-in-rats
#40
JOURNAL ARTICLE
Alexandra M Vaiana, Amber M Asher, Karla Tapia, David A Morilak
INTRODUCTION: Androgen deprivation therapy (ADT) is a mainstay treatment for prostate cancer, but many patients experience cognitive impairment in domains mediated by medial prefrontal cortex (mPFC) and hippocampus. Prostate cancer typically occurs in older patients (>65 years). As age is often accompanied by cognitive decline, it may impact the efficacy of any treatments aimed at restoring cognitive impairment induced by ADT. Vortioxetine, a multimodal antidepressant that improves cognition in depression, has been shown to be efficacious in elderly patients...
December 16, 2023: Neuroendocrinology
keyword
keyword
22035
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.